Dr Reddys Laboratories Share Price Today - Live Blog for May 08, 2025

After a notable 0.04% increase, Dr Reddys Laboratories Ltd's shares are now trading at ₹1,147.30. This surge signifies heightened investor interest in acquiring the stock. The stock has a debt to equity ratio of 0.1579 and an ROE of 17.3623%.

Dr Reddys Laboratories Ltd witnessed a -0.16% decrease in its share price, and it is currently trading at ₹1,148.65. This decline has prompted discussions among investors regarding the stock's performance and outlook. The stock has a PE ratio of 18.0200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

Dr Reddys Laboratories Ltd witnessed a notable 0.40% surge in its share price and is presently trading at ₹1,150.55, captivating the attention of market participants.

The stock of Dr Reddys Laboratories Ltd has experienced a -0.11% drop, and it's now trading at ₹1,147.00 per share. This decline has sparked discussions within the investment community regarding the stock's future prospects.

With a -0.06% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,148.30. Investors should examine the factors driving this decline. The stock's PE ratio is 18.0200, whereas the industry PE ratio stands at 34.1182.

After a -0.33% decline, Dr Reddys Laboratories Ltd shares are now trading at ₹1,149.00. The stock has a PE ratio of 18.0200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The stock of Dr Reddys Laboratories Ltd suffered a -0.02% drop, and it's now trading at ₹1,152.80 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.09%, and as of now, it's trading at ₹1,153.00 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd stock remained unchanged, maintaining its position at ₹1,152.00. During this period of price stability, investors can assess the stock's competitive advantages and market positioning.

The stock of Dr Reddys Laboratories Ltd suffered a -0.33% drop, and it's now trading at ₹1,152.00 per share. Investors are assessing whether this decline represents a buying opportunity or a sign of ongoing challenges.

Dr Reddys Laboratories Ltd witnessed a notable 0.23% surge in its share price and is presently trading at ₹1,154.75, captivating the attention of market participants.

The share price of Dr Reddys Laboratories Ltd experienced a -0.06% slump and is currently trading at ₹1,152.10. While the stock maintains a PE ratio of 18.0200, the industry PE is 34.1182, raising questions about valuation.

The share price of Dr Reddys Laboratories Ltd experienced an uptrend, surging by 0.11% recently. As of now, this stock is actively trading at a current market price of ₹1,151.30 per share, attracting attention from investors.

Dr Reddys Laboratories Ltd share price has declined by -0.17%, and it's currently trading at ₹1,150.00. The stock maintains a PE of 18.0200, while the industry PE is 34.1182, prompting discussions about its valuation.

Dr Reddys Laboratories Ltd's stock has surged by 0.03%, and it is currently trading at ₹1,152.80. Additionally, the stock maintains a PE ratio of 18.0200, while the industry PE is 34.1182.

Dr Reddys Laboratories Ltd's stock has risen by a substantial 0.06%, and as of now, it's trading at ₹1,150.80 per share. This upward trajectory is attracting keen interest from investors.

Dr Reddys Laboratories Ltd's share price has fallen by -0.10%, a situation worth noting. At present, the stock is trading at ₹1,150.30. Investors might find this a moment to reassess their positions. The stock's current Price-to-Earnings (PE) ratio stands at 18.0200, while the industry PE ratio is 34.1182.

Dr Reddys Laboratories Ltd's share price has experienced a notable 0.09% upswing, and it's currently trading at ₹1,151.00 per share. Investors are closely watching this development.

The stock of Dr Reddys Laboratories Ltd is on the rise, registering an impressive 0.02% increase and currently trading at ₹1,150.60 per share. Investors are taking notice of this upward momentum.

The stock of Dr Reddys Laboratories Ltd is facing a -0.51% decline and is currently trading at ₹1,150.00 per share. Investors are closely monitoring this situation for potential signs of a turnaround.

Dr Reddys Laboratories Ltd observed a -0.36% decrease in its share price, a situation that merits attention. As of now, it's actively trading at ₹1,155.10. The stock has a PE ratio of 18.0200, an ROE of 17.3623% and a debt to equity ratio of 0.1579.

The share price of Dr Reddys Laboratories Ltd soared by an impressive 1.00%, marking a substantial gain for investors. At present, this stock can be acquired at a current market price of ₹1,160.85 per share.

The share price of Dr Reddys Laboratories Ltd experienced a -0.00% slump and is currently trading at ₹1,150.25. While the stock maintains a PE ratio of 18.0200, the industry PE is 34.1182, raising questions about valuation.

Dr Reddys Laboratories Ltd witnessed a substantial 0.03% increase in its share price and is currently trading at ₹1,149.20. This remarkable performance has caught the eye of investors.

Demonstrating a commendable 0.32% gain, Dr Reddys Laboratories Ltd's share price is currently situated at ₹1,148.70. In terms of valuation, the stock maintains a PE ratio of 18.0200, while the industry PE ratio stands at 34.1182.

With a -1.21% decrease, Dr Reddys Laboratories Ltd's share price is now ₹1,146.05. Investors should examine the factors driving this decline. The stock's PE ratio is 18.0200, whereas the industry PE ratio stands at 34.1182.